C HEALTH GP released its annual performance, with a loss attributable to shareholders of 14.519 million yuan, a year-on-year decrease of 74.97%
C HEALTH GP released its annual performance for the year ended December 31, 2024, with operating revenue of 26.454 million yuan, a year-on-year increase of 23.47%. The loss attributable to shareholders was 14.519 million yuan, a year-on-year decrease of 74.97%, with a loss per share of 1.46 cents. The net loss for 2024 was approximately 14.519 million yuan, mainly due to a significant decrease in the provision for impairment of financial assets
According to the Zhitong Finance APP, China Medical Group (08225) announced its annual performance for the year ending December 31, 2024. The group achieved operating revenue of RMB 26.454 million, an increase of 23.47% year-on-year; the loss attributable to equity holders of the company was RMB 14.519 million, a decrease of 74.97% year-on-year; the loss per share was 1.46 cents.
The net loss for 2024 was approximately RMB 14.519 million, compared to a loss of approximately RMB 58.211 million in 2023. The main reason was the impairment provision for financial assets based on expected credit losses, which decreased from RMB 58.937 million in 2023 to RMB 14.836 million in 2024
